Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Agents for BPH disclosed by Merck & Co.

Feb. 19, 1997

Natural 5alpha-reductase inhibitors discovered at Taisho

Feb. 10, 1997

Dual-action compounds for BPH described by Zeria

Feb. 10, 1997

Cypress awarded grant for research related to its PROSORBA Column

Feb. 7, 1997

Tanabe Seiyaku discloses novel antinephritic compounds

Feb. 6, 1997

Pollakiuria treatment described by SS Pharm.

Feb. 6, 1997

Merck & Co. pursues alpha1a-adrenoceptor antagonists for BPH

Feb. 5, 1997

New SOD-CAT mimetic shows potential in situations of acute ischemia-reperfusion

Jan. 29, 1997

Kotobuki discloses muscarinic antagonists

Jan. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026